Prediction of response to systemic treatment by kinetics of circulating tumor DNA in metastatic pancreatic cancer

Abstract

The change in magnitude of ctDNA during systemic treatment allows the prediction of treatment response and is associated with both OS and PFS. This finding adds significant clinical potential to the already established prognostic value of ctDNA positivity in metastatic pancreatic cancer.